Pentavalent vaccine not cause of Ujjain infant’s death, says lab test | indore | Hindustan Times
Today in New Delhi, India
Jan 24, 2017-Tuesday
New Delhi
  • Humidity
  • Wind

Pentavalent vaccine not cause of Ujjain infant’s death, says lab test

indore Updated: Mar 24, 2015 18:49 IST
HT Correspondent
HT Correspondent
Hindustan Times
Highlight Story

MP Health department and the Ujjain district vaccination officer heaved a sigh of relief on Monday after the Central Drug Laboratory (CDL) at CRI Kasauli gave a clean chit to the Pentavalent vaccine after a laboratory test.

The vaccine sample was sent to the laboratory for testing after a one-and-half month-old boy died around 18 hours after he was administered a dose of the vaccine on November 16 here in Ujjain on November 16, last year.

Bharat, son of Devendra Garg, from Begampura under Mahakal police station limit was administered a vaccine at Ujjain’s district hospital on November 15 and on next day (around 18-hours later) he developed loose motions and vomiting.

Infant's parents immediately rushed him to the district hospital where doctors declared him brought dead. The aggrieved family members also created a ruckus at the hospital, blaming the vaccine for the death of their child.

Responding to the allegations, team of four doctors, including Dr JS Dhawan, Dr KN Tripathi, Dr Ambuj Agrawal and Dr Jitendra Sharma performed a post mortem, which claimed that the child, Bharat, had died due to suffocation.

To avoid any further casualty due to vaccination in the district, the health department had sent the vaccine to the CDL for testing. After examination, laboratory on Monday gave a clean chit to the vaccine.

Earlier, on October 29, the health department has launched a new immunisation campaign for children under one year and included Pentavalent vaccine on the list of generic medicines.

The new vaccine is to be used against five diseases -- diphtheria, tetanus, whooping cough, hepatitis B and haemophilus influenza type B. It costs about Rs1,300 in the open market, but the health department is providing it free in government hospitals.